vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Legacy Housing Corp (LEGH). Click either name above to swap in a different company.
Legacy Housing Corp is the larger business by last-quarter revenue ($25.5M vs $20.0M, roughly 1.3× AGIOS PHARMACEUTICALS, INC.). Legacy Housing Corp runs the higher net margin — 32.2% vs -541.1%, a 573.3% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -30.6%). Legacy Housing Corp produced more free cash flow last quarter ($15.7M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs -9.1%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Legacy Housing Corp is a prominent U.S.-based manufacturer of affordable manufactured homes, tiny homes, and accessory dwelling units. It mainly caters to low- and middle-income consumers across North America, providing customizable residential solutions, supporting construction materials, and after-sales services for individual and community development clients.
AGIO vs LEGH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $25.5M |
| Net Profit | $-108.0M | $8.2M |
| Gross Margin | 90.6% | 26.4% |
| Operating Margin | -608.9% | 40.4% |
| Net Margin | -541.1% | 32.2% |
| Revenue YoY | 86.1% | -30.6% |
| Net Profit YoY | -11.9% | -43.5% |
| EPS (diluted) | $-1.86 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $25.5M | ||
| Q3 25 | $12.9M | $28.8M | ||
| Q2 25 | $12.5M | $38.4M | ||
| Q1 25 | $8.7M | $24.3M | ||
| Q4 24 | $10.7M | $36.7M | ||
| Q3 24 | $9.0M | $30.2M | ||
| Q2 24 | $8.6M | $31.7M | ||
| Q1 24 | $8.2M | $30.8M |
| Q4 25 | $-108.0M | $8.2M | ||
| Q3 25 | $-103.4M | $8.6M | ||
| Q2 25 | $-112.0M | $14.7M | ||
| Q1 25 | $-89.3M | $10.3M | ||
| Q4 24 | $-96.5M | $14.5M | ||
| Q3 24 | $947.9M | $15.8M | ||
| Q2 24 | $-96.1M | $16.2M | ||
| Q1 24 | $-81.5M | $15.1M |
| Q4 25 | 90.6% | 26.4% | ||
| Q3 25 | 87.0% | 20.2% | ||
| Q2 25 | 86.3% | 32.4% | ||
| Q1 25 | 87.6% | 29.2% | ||
| Q4 24 | 88.3% | 27.3% | ||
| Q3 24 | 91.3% | 29.2% | ||
| Q2 24 | 82.6% | 31.9% | ||
| Q1 24 | 92.3% | 33.6% |
| Q4 25 | -608.9% | 40.4% | ||
| Q3 25 | -907.4% | 33.7% | ||
| Q2 25 | -1020.1% | 43.8% | ||
| Q1 25 | -1222.0% | 47.7% | ||
| Q4 24 | -1165.3% | 42.3% | ||
| Q3 24 | -1146.9% | 50.8% | ||
| Q2 24 | -1228.3% | 50.6% | ||
| Q1 24 | -1124.3% | 54.3% |
| Q4 25 | -541.1% | 32.2% | ||
| Q3 25 | -803.1% | 30.0% | ||
| Q2 25 | -899.4% | 38.3% | ||
| Q1 25 | -1023.3% | 42.3% | ||
| Q4 24 | -899.6% | 39.5% | ||
| Q3 24 | 10574.7% | 52.4% | ||
| Q2 24 | -1115.7% | 51.1% | ||
| Q1 24 | -995.8% | 49.1% |
| Q4 25 | $-1.86 | $0.38 | ||
| Q3 25 | $-1.78 | $0.35 | ||
| Q2 25 | $-1.93 | $0.60 | ||
| Q1 25 | $-1.55 | $0.41 | ||
| Q4 24 | $-1.44 | $0.59 | ||
| Q3 24 | $16.22 | $0.64 | ||
| Q2 24 | $-1.69 | $0.65 | ||
| Q1 24 | $-1.45 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $8.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $528.6M |
| Total Assets | $1.3B | $580.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $8.5M | ||
| Q3 25 | $92.7M | $13.6M | ||
| Q2 25 | $80.9M | $2.6M | ||
| Q1 25 | $79.0M | $3.4M | ||
| Q4 24 | $76.2M | $1.1M | ||
| Q3 24 | $253.7M | $570.0K | ||
| Q2 24 | $84.5M | $60.0K | ||
| Q1 24 | $118.8M | $621.0K |
| Q4 25 | $1.2B | $528.6M | ||
| Q3 25 | $1.3B | $521.6M | ||
| Q2 25 | $1.4B | $512.8M | ||
| Q1 25 | $1.5B | $503.7M | ||
| Q4 24 | $1.5B | $494.0M | ||
| Q3 24 | $1.6B | $479.3M | ||
| Q2 24 | $660.5M | $463.2M | ||
| Q1 24 | $743.9M | $450.4M |
| Q4 25 | $1.3B | $580.3M | ||
| Q3 25 | $1.4B | $557.9M | ||
| Q2 25 | $1.5B | $552.0M | ||
| Q1 25 | $1.6B | $544.6M | ||
| Q4 24 | $1.7B | $534.2M | ||
| Q3 24 | $1.8B | $521.4M | ||
| Q2 24 | $773.1M | $514.9M | ||
| Q1 24 | $849.7M | $510.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $19.0M |
| Free Cash FlowOCF − Capex | $-97.3M | $15.7M |
| FCF MarginFCF / Revenue | -487.5% | 61.6% |
| Capex IntensityCapex / Revenue | 5.6% | 13.1% |
| Cash ConversionOCF / Net Profit | — | 2.32× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $28.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $19.0M | ||
| Q3 25 | $-88.2M | $7.2M | ||
| Q2 25 | $-77.1M | $6.1M | ||
| Q1 25 | $-111.5M | $4.9M | ||
| Q4 24 | $-133.2M | $7.9M | ||
| Q3 24 | $-84.2M | $13.8M | ||
| Q2 24 | $-72.6M | $3.5M | ||
| Q1 24 | $-99.9M | $10.8M |
| Q4 25 | $-97.3M | $15.7M | ||
| Q3 25 | $-89.7M | $5.1M | ||
| Q2 25 | $-78.0M | $3.7M | ||
| Q1 25 | $-112.3M | $3.6M | ||
| Q4 24 | $-134.1M | $6.0M | ||
| Q3 24 | $-84.6M | $9.1M | ||
| Q2 24 | $-72.7M | $1.7M | ||
| Q1 24 | $-100.0M | $9.9M |
| Q4 25 | -487.5% | 61.6% | ||
| Q3 25 | -696.5% | 17.8% | ||
| Q2 25 | -626.2% | 9.6% | ||
| Q1 25 | -1286.4% | 15.0% | ||
| Q4 24 | -1250.1% | 16.4% | ||
| Q3 24 | -944.2% | 30.2% | ||
| Q2 24 | -844.4% | 5.4% | ||
| Q1 24 | -1221.2% | 32.2% |
| Q4 25 | 5.6% | 13.1% | ||
| Q3 25 | 12.1% | 7.1% | ||
| Q2 25 | 7.0% | 6.2% | ||
| Q1 25 | 8.8% | 5.2% | ||
| Q4 24 | 9.0% | 5.1% | ||
| Q3 24 | 4.7% | 15.6% | ||
| Q2 24 | 1.8% | 5.5% | ||
| Q1 24 | 1.7% | 2.8% |
| Q4 25 | — | 2.32× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | -0.09× | 0.88× | ||
| Q2 24 | — | 0.21× | ||
| Q1 24 | — | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
LEGH
| Commercial Sales | $8.6M | 34% |
| Retail Store Sales | $6.0M | 24% |
| Inventory Finance Sales | $5.0M | 20% |
| Direct Sales | $4.4M | 17% |
| Other | $1.5M | 6% |
